Gagnon Securities’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$864K Buy
12,230
+2,351
+24% +$127K 0.17% 49
2026
Q1
$516K Buy
9,879
+265
+3% +$15.9K 0.12% 57
2025
Q4
$565K Hold
9,614
0.12% 58
2025
Q3
$535K Buy
9,614
+344
+4% +$18.4K 0.11% 58
2025
Q2
$477K Buy
9,270
+327
+4% +$16.4K 0.1% 60
2025
Q1
$524K Buy
8,943
+1,085
+14% +$73.5K 0.12% 58
2024
Q4
$566K Buy
7,858
+489
+7% +$35.9K 0.11% 59
2024
Q3
$589K Buy
7,369
+253
+4% +$19K 0.12% 57
2024
Q2
$510K Buy
7,116
+82
+1% +$6.04K 0.11% 58
2024
Q1
$495K Buy
7,034
+2,170
+45% +$155K 0.12% 60
2023
Q4
$375K Buy
4,864
+932
+24% +$61.4K 0.09% 61
2023
Q3
$268K Buy
+3,932
New +$311K 0.07% 75

Other funds holding TECH

Gagnon Securities's TECH Position: Q2 2026 in Review

Gagnon Securities increased its Bio-Techne (TECH) stake by 24% in Q2 2026, buying an estimated $127K and bringing the position to 12,230 shares worth $864K. The position accounts for 0.17% of the portfolio, ranked #49.

Gagnon Securities first reported a position in TECH in Q3 2023 and has held it in 12 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Gagnon Securities held 12,230 shares of Bio-Techne worth $864K as of Q2 2026.
  • Gagnon Securities bought 2,351 Bio-Techne shares in Q2 2026, an estimated $127K.
  • Bio-Techne made up 0.17% of Gagnon Securities's portfolio in Q2 2026, its #49 holding.
  • Gagnon Securities first reported a position in Bio-Techne in Q3 2023 and has held it in 12 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Gagnon Securities's 13F filing for Q2 2026, filed 5 Aug 2026.